Sir: A clinical and EEG reversible syndrome due to lithium toxicity that resembles Creutzfeldt-Jakob disease has recently been described in the Journal.' Although the authors claim that their two cases constitute the first report in the English literature, we would like to describe a personal observation that we published in 1972 in a French medical journal. 2 The patient was a 70 year old female who was admitted at the Department of Neurology in April 1971 with a Parkinsonian syndrome. She had experienced for 2 years resting tremor and dysarthria. Neurological examination, while the patient was under no medication, revealed akinesia, rigidity, tremor prominent in the left lower limb, bradyphrenia and mild memory impairment. The first EEG record showed intermittent slow activity of 2-3 Hz (fig). Routine haematology and biochemistry tests, including thyroid function, were normal.
Since the patient presented with an atypical parkinsonism with depression, levodopa plus lithium therapy was started. On the 10th day after admission, levodopa (without dopa decarboxylase inhibitor) was introduced progressively, reaching a daily dose of 2 g within 6 days. Lithium gluconate at a daily dose of 12 g was added 13 days after admission. On the 19th day, the patient became confused and agitated, and treatment was stopped. Nonetheless she worsened during the next 48 hours, presenting with a precomatose state, mutism, rigidity, sporadic myoclonic jerks that were prominent in the lower limbs, and urinary incontinency. The second EEG at that time was dramatically different from the first one (see fig) , with increased theta activity of 5 Hz, and delta activity, predominantly in the frontal fields. Moreover there were triphasic waves and sharp waves particularly in the frontal fields, that were not synchronised with the concomittent myoclonic jerks of the upper limbs. Five mg diazepam IV suppressed for 4 
